Evidence map›Paper›PMID 30390322›Full record

ArticleJournal of clinical laboratory analysis2019

Diagnosing malignant pleural effusion using clinical and analytical parameters.

Yong Pan, Wenjing Bai, Jiangnan Chen, Yijian Mao, Xiaohong Qian, Ke Xu, Shaohua Tang, Junwu Zhang, Chong Chen, Jingyi Chen and 1 more

Abstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yong PanDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Wenjing BaiDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Jiangnan ChenDepartment of Clinical Laboratory Medicine, ShaoXing Municipal Hospital, Shao Xing, China.
Yijian MaoDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Xiaohong QianDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Ke XuDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Shaohua TangDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Junwu ZhangDepartment of Clinical Laboratory Medicine, Wenzhou Traditional Chinese Medicine Hospital, Wenzhou, China.
Chong ChenDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Jingyi ChenDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Xingzhong HuDepartment of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant pleural effusion (MPE) is common and diagnosis is often problematic. A cancer ratio (serum lactate dehydrogenases: pleural adenosine deaminase ratio) has been proposed for diagnosing MPE. However, the usefulness of this "cancer ratio" and the clinical-radiological criteria for diagnosing MPE has not been clearly determined to date. The aim of this study was to assess the performance of those parameters in the diagnosis of MPE.

methodsWe analyzed 240 patients including 120 with MPE and 120 with non-MPE (93 tuberculous and 27 parapneumonic). Patients were divided into two groups: MPE and non-MPE (eg, tuberculous and parapneumonic). We constructed two predictive models to assess the probability of MPE: (a) clinical-radiological data only and (b) a combination of clinical-radiological data, the cancer ratio, and the carcinoembryonic antigen (CEA). The performances of the predictive models were assessed using receiver operating characteristic (ROC) curves and by examining the calibration.

resultsThe area under the ROC curves for model 1 and model 2 were excellent, 0.936 and 0.998, respectively. The overall diagnostic accuracies for model 1 and model 2 were 87.5% and 98.8%, respectively.

conclusionThe results confirm that both models achieved a high diagnostic accuracy for MPE; however, model 2 was superior with the addition of its simplicity of use in daily practice. This model should be applied to determine which patients with a pleural effusion of unknown origin would not benefit from further invasive procedures.

Indexed as

AgedAged, 80 and overBiomarkers, TumorCarcinoembryonic AntigenCase-Control StudiesFemaleHumansMaleMiddle AgedPleural Effusion, MalignantPredictive Value of TestsRadiographyROC CurveBiomarkers, TumorCarcinoembryonic Antigendiagnosislactate dehydrogenaseslogistic modelsmalignantpleural effusion

Identifiers

PMID30390322
PMCPMC6818593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.